Position in VTRS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,206,165
+$427,935 QoQ
Shares Held
75,955
+31.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#296
of 1,016 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $122,719,355 across 16 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,409,759 | $112,400,085 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
77,986 | $2,642,165 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
55,602 | $1,368,365 | |
| 4 | VTRS |
Viatris Inc
This page
|
75,955 | $1,206,165 | |
| 5 | ZTS |
Zoetis Inc.
|
13,819 | $993,033 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
40,725 | $652,821 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
3,295 | $555,339 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
32,404 | $469,533 |
All Filings in VTRS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,206,165 | 75,955 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $778,230 | 57,604 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $635,684 | 51,059 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $309,276 | 31,240 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $465,584 | 53,454 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,179,724 | 94,757 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,047,163 | 90,195 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $991,406 | 93,265 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||